- All sections
- A - Human necessities
- A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
- A61P 37/04 - Immunostimulants
Patent holdings for IPC class A61P 37/04
Total number of patents in this class: 5968
10-year publication summary
|
103
|
132
|
188
|
259
|
244
|
328
|
411
|
411
|
577
|
388
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Glaxosmithkline Biologicals S.A. | 1649 |
68 |
| The Trustees of the University of Pennsylvania | 4342 |
58 |
| The Regents of the University of California | 20087 |
57 |
| Osaka University | 3388 |
44 |
| National Research Council of Canada | 1547 |
40 |
| Bristol-myers Squibb Company | 4855 |
36 |
| The Governors of the University of Alberta | 873 |
36 |
| University of Saskatchewan | 481 |
35 |
| The University of British Columbia | 1509 |
33 |
| Toray Industries, Inc. | 6978 |
30 |
| Nestec S.A. | 2653 |
29 |
| Memorial Sloan-Kettering Cancer Center | 1949 |
29 |
| Universite de Montreal | 341 |
28 |
| Merck Sharp & Dohme LLC | 3757 |
27 |
| President and Fellows of Harvard College | 5998 |
26 |
| Inovio Pharmaceuticals, Inc. | 322 |
25 |
| Kyoto University | 2811 |
25 |
| Immatics Biotechnologies GmbH | 1153 |
24 |
| Riken | 1695 |
24 |
| The University of Tokyo | 4208 |
24 |
| Other owners | 5270 |